Yesterday, the House Energy and Commerce Committee debated the merits of H.R.3, a proposal released by Speaker of the House […]
Gerard Scimeca – Chairman, CASE September 22, 2019 FEW CAN argue how the global economy is undergoing a tremendous […]
September 19, 2019 (Arlington, Virginia) — Today, CASE Vice President Gerard Scimeca issued a statement, condemning Speaker of the […]
Gerard Scimeca – Chairman, CASE September 14, 2019 The Godfather author Mario Puzo once said one lawyer with a briefcase can […]
September 12, 2019 Earlier this week, a draft of Speaker of the House Nancy Pelosi’s drug pricing plan was leaked […]
September 10, 2019 Gerard Scimeca – Chairman, CASE Just when we thought the world sugar market could not get any […]
Gerard Scimeca – Chairman, CASE August 21, 2019 New York Attorney General Letitia James seems to be a little confused. […]
August 16, 2019 Last month, The Centers for Medicare and Medicaid Services released a new proposal which will increase price […]
Matthew Kandrach – President, CASE August 13, 2019 Is it time to shut down nuclear power plants? Some opponents of […]
AARP has taken over $4.5 billion from health insurance companies and is now actively working to persuade lawmakers to support […]
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/